1018 related articles for article (PubMed ID: 25626558)
21. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
[TBL] [Abstract][Full Text] [Related]
22. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
23. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T
Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
25. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
26. Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease.
Smith ML; King J; Dent L; Mackey V; Muthian G; Griffin B; Charlton CG
Life Sci; 2014 Aug; 110(1):1-7. PubMed ID: 24880075
[TBL] [Abstract][Full Text] [Related]
27. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
[TBL] [Abstract][Full Text] [Related]
28. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
Borah A; Mohanakumar KP
Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760
[TBL] [Abstract][Full Text] [Related]
29. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
[TBL] [Abstract][Full Text] [Related]
30. Role of ethanolic extract of Bacopa monnieri against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mice model via inhibition of apoptotic pathways of dopaminergic neurons.
Singh B; Pandey S; Yadav SK; Verma R; Singh SP; Mahdi AA
Brain Res Bull; 2017 Oct; 135():120-128. PubMed ID: 29032054
[TBL] [Abstract][Full Text] [Related]
31. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
Yadav SK; Pandey S; Singh B
J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
[TBL] [Abstract][Full Text] [Related]
32. Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Viaro R; Marti M; Morari M
Exp Neurol; 2010 Jun; 223(2):473-84. PubMed ID: 20122926
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Teismann P; Ferger B
Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
[TBL] [Abstract][Full Text] [Related]
34. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice.
Liu Q; Zhu D; Jiang P; Tang X; Lang Q; Yu Q; Zhang S; Che Y; Feng X
Behav Brain Res; 2019 Jul; 367():10-18. PubMed ID: 30922940
[TBL] [Abstract][Full Text] [Related]
36. Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice.
Purushothuman S; Nandasena C; Peoples CL; El Massri N; Johnstone DM; Mitrofanis J; Stone J
J Parkinsons Dis; 2013; 3(1):77-83. PubMed ID: 23938314
[TBL] [Abstract][Full Text] [Related]
37. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
Park G; Park YJ; Yang HO; Oh MS
Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
[TBL] [Abstract][Full Text] [Related]
38. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
39. Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice.
Fredriksson A; Palomo T; Archer T
J Neural Transm (Vienna); 1999; 106(9-10):889-909. PubMed ID: 10599871
[TBL] [Abstract][Full Text] [Related]
40. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
